Coenzyme Q10 (coq10 lp, coq10 mito porter) is a mitochondrial protective therapeutic supplementation agent that functions in mitochondrial-targeted delivery contexts and is used to support mitochondrial function. It has a clear precision-medicine role in steroid-resistant nephrotic syndrome, where supplementation benefits cases with coq2 or pdss2 mutations, consistent with its role as a treatment for primary CoQ biosynthesis defects. In liver injury, CoQ10-loaded nanocarriers were reported to alleviate early acetaminophen-induced liver injury, and TPP+-modified liposomes can effectively deliver coenzyme Q10 to mitochondria. Recent literature also highlights mitochondrial-targeted delivery systems as a broader strategy for diseases involving mitochondrial dysfunction, including atherosclerosis. Key facts indicate its therapeutic supplementation role and mutation responsiveness in COQ2/PDSS2-associated disease.
Genetic disease
- Coenzyme Q10 supplementation benefited steroid-resistant nephrotic syndrome cases with coq2 or pdss2 mutations, supporting a precision-treatment approach for CoQ biosynthesis defects. (PMID:41898355)
- The SRNS review emphasized precision classification, diagnosis, and treatment, placing CoQ10 in the context of gene-guided therapy. (PMID:41898355)
- The entry’s key facts specifically note that CoQ10 responds to COQ2/PDSS2 mutations, reinforcing its role as therapeutic supplementation. (PMID:41898355)
Liver injury and mitochondrial delivery
- Mitochondria-targeted CoQ10 nanocarriers, evaluated by particle size and lipid composition, alleviated early acetaminophen-induced liver injury. (PMID:41638489)
- CoQ10-loaded nanocarriers were described as a mitochondrial protective therapeutic candidate in this setting. (PMID:41638489)
- tpp+ modified liposome systems were reported to effectively deliver coenzyme Q10 to mitochondria, highlighting a targeting strategy for intracellular delivery. (PMID:41668545)
- The review on mitochondrial dysfunction and targeted delivery systems places CoQ10 within broader applications for diseases such as atherosclerosis. (PMID:41668545)